Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model.

MLA

Rybczynski, Philip J., et al. “Benzoxazinones as PPARgamma Agonists. 2. SAR of the Amide Substituent and in Vivo Results in a Type 2 Diabetes Model.” Journal of Medicinal Chemistry, vol. 47, no. 1, Jan. 2004, pp. 196–209. EBSCOhost, https://doi.org/10.1021/jm0301888.

APA

Rybczynski, P. J., Zeck, R. E., Dudash, J., Jr, Combs, D. W., Burris, T. P., Yang, M., Osborne, M. C., Chen, X., & Demarest, K. T. (2004). Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model. Journal of Medicinal Chemistry, 47(1), 196–209. https://doi.org/10.1021/jm0301888

Chicago

Rybczynski, Philip J, Roxanne E Zeck, Joseph Dudash Jr, Donald W Combs, Thomas P Burris, Maria Yang, Melville C Osborne, Xiaoli Chen, and Keith T Demarest. 2004. “Benzoxazinones as PPARgamma Agonists. 2. SAR of the Amide Substituent and in Vivo Results in a Type 2 Diabetes Model.” Journal of Medicinal Chemistry 47 (1): 196–209. doi:10.1021/jm0301888.